Loss of TREM2 rescues hyperactivation of microglia, but not lysosomal deficits and neurotoxicity in models of progranulin deficiency
Open accessThe DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
Haploinsufficiency of the progranulin (PGRN)-encoding gene (GRN) causes frontotemporal lobar degeneration (GRN-FTLD) and results in microglial hyperactivation, TREM2 activation, lysosomal dysfunction, and TDP-43 deposition. To understand the contribution of microglial hyperactivation to pathology, we used genetic and pharmacological approaches to suppress TREM2-dependent transition of microglia from a homeostatic to a disease-associated state. Trem2 deficiency in Grn KO mice reduced microglia hyperactivation. To explore antibody-mediated pharmacological modulation of TREM2-dependent microglial states, we identified antagonistic TREM2 antibodies. Treatment of macrophages from GRN-FTLD patients with these antibodies led to reduced TREM2 signaling due to its enhanced shedding. Furthermore, TREM2 antibody-treated PGRN-deficient microglia derived from human-induced pluripotent stem cells showed reduced microglial hyperactivation, TREM2 signaling, and phagocytic activity, but lysosomal dysfunction was not rescued. Similarly, lysosomal dysfunction, lipid dysregulation, and glucose hypometabolism of Grn KO mice were not rescued by TREM2 ablation. Synaptic loss and neurofilament light-chain (NfL) levels, a biomarker for neurodegeneration, were further elevated in the Grn/Trem2 KO cerebrospinal fluid (CSF). These findings suggest that TREM2-dependent microglia hyperactivation in models of GRN deficiency does not promote neurotoxicity, but rather neuroprotection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures














Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, microglial activation may also be protective in these neurodegenerative conditions, for example by enhancing microglia phagocytosis of amyloid plaques in the context of AD (176–178).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [178]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493 · cited 3×
“Moreover, a loss of TREM2 function locks microglia in a dysfunctional homeostatic state (Keren-Shaul et al , 2017; Krasemann et al , 2017; Mazaheri et al , 2017; Nugent et al , 2020), in which they are unable to respond to pathological challenges by inducing a disease-associated mRNA signature.”
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343 · cited 2×
“Although increased TREM2 may be protective in AD patients (Ewers et al , 2019), in other neurodegenerative diseases, microglia may be overactivated and become dysfunctional (Heneka et al , 2013; Hong et al , 2016a; Ransohoff, 2016).”
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 1×
“…upon functional investigations of coding variants found within the triggering receptor expressed on myeloid cells 2 (TREM2) gene, which can increase the risk for LOAD and other neurogenerative disorders including frontotemporal dementia-like syndromes (Guerreiro et al , 2013; Jonsson et al , 2013).”
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979 · cited 2×
“Moreover, a loss of TREM2 function locks microglia in a dysfunctional homeostatic state (Keren-Shaul et al , 2017; Krasemann et al , 2017; Mazaheri et al , 2017; Nugent et al , 2020), in which they are unable to respond to pathological challenges by inducing a disease-associated mRNA signature.”
Self-citationNLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens
Concordet, J.-P., & Haeussler, M. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky354 · Cited by 2,655
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 1×
“…upon functional investigations of coding variants found within the triggering receptor expressed on myeloid cells 2 (TREM2) gene, which can increase the risk for LOAD and other neurogenerative disorders including frontotemporal dementia-like syndromes (Guerreiro et al , 2013; Jonsson et al , 2013).”
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058
How neuroinflammation contributes to neurodegeneration
Ransohoff, R. M. (2016) · Science · doi:10.1126/science.aag2590 · Cited by 1,967 · cited 2×
“Although increased TREM2 may be protective in AD patients (Ewers et al , 2019), in other neurodegenerative diseases, microglia may be overactivated and become dysfunctional (Heneka et al , 2013; Hong et al , 2016a; Ransohoff, 2016).”
Marschallinger, J., Iram, T., Zardeneta, M., Lee, S. E., Lehallier, B., Haney, M. S., Pluvinage, J. V., Mathur, V., Hahn, O., Morgens, D. W., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-019-0566-1 · Cited by 1,586 · cited 1×
“In Grn KO mice, lipid metabolism is altered (Evers et al , 2017; Marschallinger et al , 2020) and a recent study described an age-independent deficit in levels of the lysosomal lipid bis(monoacylglycerol)phosphate (BMP) that was accompanied by an age-dependent accumulation of the GCase substrate…”
Cruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512 · cited 1×
“…disorder where microglia are hyperactivated is GRN -associated frontotemporal lobar degeneration ( GRN -FTLD) with TDP-43 (transactive response DNA-binding protein 43 kDa) deposition caused by progranulin (PGRN) deficiency (Baker et al , 2006; Cruts et al , 2006; Gotzl et al , 2019).”
Marschallinger, J., Iram, T., Zardeneta, M., Lee, S. E., Lehallier, B., Haney, M. S., Pluvinage, J. V., Mathur, V., Hahn, O., Morgens, D. W., et al. (2019) · doi:10.1101/722827 · Cited by 1,414
iPSC-derived human microglia-like cells to study neurological diseases
Abud, E. M., Ramirez, R. N., Martinez, E. S., Healy, L. M., Nguyen, C. H. H., Newman, S. A., Yeromin, A. V., Scarfone, V. M., Marsh, S. E., Fimbres, C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.042 · Cited by 1,154 · cited 1×
“We differentiated hiMGL from iPSCs as described (Abud et al , 2017) with modifications to improve efficiency and yield: When iPSCs were 70 – 90% confluent, they were split 1:100 – 200 onto GelTrex-coated six-well plates for the HPC differentiation using EDTA to get around ~ 20 small colonies per…”
Dominantly Inherited Alzheimer Network, Preische, O., Schultz, S. A., Apel, A., Kuhle, J., Kaeser, S. A., Barro, C., Gräber, S., Kuder-Buletta, E., LaFougere, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0304-3 · Cited by 927 · cited 2×
“Strikingly, synapse loss was exacerbated, and neurofilament light chain (NfL), a sensitive fluid biomarker of neurodegeneration (Meeter et al , 2016; Rohrer et al , 2016; Preische et al , 2019), was also not reduced but unexpectedly increased in the cerebrospinal fluid (CSF).”
Self-citationTREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., Yuan, P., Mahan, T. E., Shi, Y., Gilfillan, S., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151948 · Cited by 840 · cited 1×
“…where they exhibit a protective function by encapsulating the protein deposits via a barrier function (Yuan et al , 2016) that promotes amyloid plaque compaction (Ulrich et al , 2014; Wang et al , 2016; Meilandt et al , 2020) and reduces de novo seeding of amyloid plaques (Parhizkar et al , 2019).”
Inflammasome signalling in brain function and neurodegenerative disease
Heneka, M. T., McManus, R. M., & Latz, E. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0055-7 · Cited by 836 · cited 1×
“This is very surprising since chronically activated microglia, as observed in PGRN loss-of-function models and mouse models for amyloid and tau pathology, would have been expected to exert significant damage within the brain, for example, by induction of the inflammasome (Heneka et al , 2018).”
Yuan, P., Condello, C., Keene, C. D., Wang, Y., Bird, T. D., Paul, S. M., Luo, W., Colonna, M., Baddeley, D., & Grutzendler, J. (2016) · Neuron · doi:10.1016/j.neuron.2016.05.003 · Cited by 817
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Kleinberger, G., Yamanishi, Y., Suárez-Calvet, M., Czirr, E., Lohmann, E., Cuyvers, E., Struyfs, H., Pettkus, N., Wenninger-Weinzierl, A., Mazaheri, F., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009093 · Cited by 798 · cited 2×
“Since evidence exists that shedding of TREM2 terminates cell autonomous signaling in myeloid cells (Kleinberger et al , 2014; Schlepckow et al , 2017, 2020; Thornton et al , 2017), these findings suggest that macrophages from GRN-FTLD patients exhibit increased TREM2 signaling, which occurs in…”
Self-citationTREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge
Nugent, A. A., Lin, K., van Lengerich, B., Lianoglou, S., Przybyla, L., Davis, S. S., Llapashtica, C., Wang, J., Kim, D. J., Xia, D., et al. (2020) · Neuron · doi:10.1016/j.neuron.2019.12.007 · Cited by 798
Self-citationLui, H., Zhang, J., Makinson, S. R., Cahill, M. K., Kelley, K. W., Huang, H.-Y., Shang, Y., Oldham, M. C., Martens, L. H., Gao, F., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.001 · Cited by 729 · cited 4×
“Similarly, mice lacking PGRN exhibit hyperactivation of microglia as indicated by an enhanced DAM signature including TREM2 and galectin 3, an increased TSPO signal, and increased phagocytic and synaptic pruning activity (Lui et al , 2016; Gotzl et al , 2019; Zhang et al , 2020).”
InfluentialCutting Edge: TREM-2 Attenuates Macrophage Activation
Turnbull, I. R., Gilfillan, S., Cella, M., Aoshi, T., Miller, M., Piccio, L., Hernandez, M., & Colonna, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3520 · Cited by 688 · cited 2×
“To determine if reduction in TREM2 signaling can ameliorate hyperactivation of PGRN-deficient microglia, we crossed Grn KO mice (Kayasuga et al , 2007) to Trem2 KO mice (Turnbull et al , 2006) and performed TSPO-PET imaging using established protocols (Liu et al , 2015; Kleinberger et al , 2017).”
Sex-specific features of microglia from adult mice
Villa, A., Gelosa, P., Castiglioni, L., Cimino, M., Rizzi, N., Pepe, G., Lolli, F., Marcello, E., Sironi, L., Vegeto, E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.048 · Cited by 651
The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway
Deczkowska, A., Weiner, A., & Amit, I. (2020) · Cell · doi:10.1016/j.cell.2020.05.003 · Cited by 648
Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk
Efthymiou, A. G., & Goate, A. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0184-x · Cited by 562
New insights on the role of microglia in synaptic pruning in health and disease
Hong, S., Dissing-Olesen, L., & Stevens, B. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.12.004 · Cited by 557
Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE
Parhizkar, S., Arzberger, T., Brendel, M., Kleinberger, G., Deussing, M., Focke, C., Nuscher, B., Xiong, M., Ghasemigharagoz, A., Katzmarski, N., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0296-9 · Cited by 555 · cited 1×
“…where they exhibit a protective function by encapsulating the protein deposits via a barrier function (Yuan et al , 2016) that promotes amyloid plaque compaction (Ulrich et al , 2014; Wang et al , 2016; Meilandt et al , 2020) and reduces de novo seeding of amyloid plaques (Parhizkar et al , 2019).”
Self-citationWang, S., Mustafa, M., Yuede, C. M., Salazar, S. V., Kong, P., Long, H., Ward, M., Siddiqui, O., Paul, R., Gilfillan, S., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200785 · Cited by 549
Sortilin-Mediated Endocytosis Determines Levels of the Frontotemporal Dementia Protein, Progranulin
Hu, F., Padukkavidana, T., Vægter, C. B., Brady, O. A., Zheng, Y., Mackenzie, I. R., Feldman, H. H., Nykjaer, A., & Strittmatter, S. M. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.034 · Cited by 536
Strikingly Different Clinicopathological Phenotypes Determined by Progranulin-Mutation Dosage
Smith, K. R., Damiano, J., Franceschetti, S., Carpenter, S., Canafoglia, L., Morbin, M., Rossi, G., Pareyson, D., Mole, S. E., Staropoli, J. F., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.04.021 · Cited by 489 · cited 2×
“PGRN and the proteolytically derived granulin peptides may have important lysosomal functions, as exemplified by the identification of homozygous loss-of-function GRN mutations, which are causative for NCL (Smith et al , 2012).”
McQuade, A., Coburn, M., Tu, C. H., Hasselmann, J., Davtyan, H., & Blurton-Jones, M. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0297-x · Cited by 449
Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
Rohrer, J. D., Woollacott, I. O. C., Dick, K. M., Brotherhood, E., Gordon, E., Fellows, A., Toombs, J., Druyeh, R., Cardoso, M. J., Ourselin, S., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003154 · Cited by 432
TREM2 variants: new keys to decipher Alzheimer disease pathogenesis
Colonna, M., & Wang, Y. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.7 · Cited by 418
Cignarella, F., Filipello, F., Bollman, B., Cantoni, C., Locca, A., Mikesell, R., Manis, M., Ibrahim, A., Deng, L., Benitez, B. A., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02193-z · Cited by 418 · cited 2×
“…amyloidosis, and supported axon regeneration and remyelination in models of demyelinating disorders such as multiple sclerosis (Cheng et al , 2018; Cignarella et al , 2020; Lewcock et al , 2020; Price et al , 2020; Schlepckow et al , 2020; Wang et al , 2020; Bosch-Queralt et al , 2021; Ellwanger…”
Spiegel, I., Mardinly, A. R., Gabel, H. W., Bazinet, J. E., Couch, C. H., Tzeng, C. P., Harmin, D. A., & Greenberg, M. E. (2014) · Cell · doi:10.1016/j.cell.2014.03.058 · Cited by 416
Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE
Parhizkar, S., Arzberger, T., Brendel, M., Kleinberger, G., Deußing, M., Focke, C., Nuscher, B., Xiong, M., Ghasemigharagoz, A., Katzmarski, N., et al. (2019) · doi:10.7892/boris.125653 · Cited by 352
Self-citationTREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury
Mazaheri, F., Snaidero, N., Kleinberger, G., Madore, C., Daria, A., Werner, G., Krasemann, S., Capell, A., Trümbach, D., Wurst, W., et al. (2017) · The EMBO Reports · doi:10.15252/embr.201743922 · Cited by 351 · cited 4×
“Moreover, a loss of TREM2 function locks microglia in a dysfunctional homeostatic state (Keren-Shaul et al , 2017; Krasemann et al , 2017; Mazaheri et al , 2017; Nugent et al , 2020), in which they are unable to respond to pathological challenges by inducing a disease-associated mRNA signature.”
InfluentialSelf-citationEwers, M., Franzmeier, N., Suárez-Calvet, M., Morenas-Rodriguez, E., Caballero, M. A. A., Kleinberger, G., Piccio, L., Cruchaga, C., Deming, Y., Dichgans, M., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav6221 · Cited by 327 · cited 1×
“Although increased TREM2 may be protective in AD patients (Ewers et al , 2019), in other neurodegenerative diseases, microglia may be overactivated and become dysfunctional (Heneka et al , 2013; Hong et al , 2016a; Ransohoff, 2016).”
Self-citationEnhancing protective microglial activities with a dual function TREM2 antibody to the stalk region
Schlepckow, K., Monroe, K. M., Kleinberger, G., Cantuti‐Castelvetri, L., Parhizkar, S., Xia, D., Willem, M., Werner, G., Pettkus, N., Brunner, B., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911227 · Cited by 324 · cited 5×
“In analogy to the agonistic 4D9 TREM2 antibody developed earlier in our laboratory (Schlepckow et al , 2020), we therefore generated monoclonal antibodies with opposite, namely antagonistic, properties.”
InfluentialSelf-citationProgranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury
Martens, L. H., Zhang, J., Barmada, S. J., Zhou, P., Kamiya, S., Sun, B., Min, S.-W., Gan, L., Finkbeiner, S., Huang, E. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63113 · Cited by 315
Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2
Ulrich, J. D., Finn, M. B., Wang, Y., Shen, A., Mahan, T. E., Jiang, H., Stewart, F. R., Piccio, L., Colonna, M., & Holtzman, D. M. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-20 · Cited by 302 · cited 1×
“…where they exhibit a protective function by encapsulating the protein deposits via a barrier function (Yuan et al , 2016) that promotes amyloid plaque compaction (Ulrich et al , 2014; Wang et al , 2016; Meilandt et al , 2020) and reduces de novo seeding of amyloid plaques (Parhizkar et al , 2019).”
Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology
Lee, S.-H., Meilandt, W. J., Xie, L., Gandham, V. D., Ngu, H., Barck, K. H., Rezzonico, M. G., Imperio, J., Lalehzadeh, G., Huntley, M. A., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.02.010 · Cited by 300 · cited 2×
“However, our findings together with those by Lee et al (2021) rather suggest that TREM2-dependent chronic activation is protective, which may have implications for therapeutic attempts employing modulation of TREM2 activity by agonistic antibodies (Deczkowska et al , 2020; Lewcock et al , 2020).”
Xiang, X., Wind, K., Wiedemann, T., Blume, T., Shi, Y., Briel, N., Beyer, L., Biechele, G., Eckenweber, F., Zatcepin, A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe5640 · Cited by 268 · cited 1×
“TSPO-PET imaging in mice is rather specific for microglial activation, as plexin treatment and ablation of TREM2, both of which reduce microglia numbers, strongly reduce the TSPO signal (Xiang et al , 2021).”
Self-citationNeurofilament light chain: a biomarker for genetic frontotemporal dementia
Meeter, L. H., Dopper, E. G., Jiskoot, L. C., Sanchez‐Valle, R., Graff, C., Benussi, L., Ghidoni, R., Pijnenburg, Y. A., Borroni, B., Galimberti, D., et al. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.325 · Cited by 263 · cited 2×
“Strikingly, synapse loss was exacerbated, and neurofilament light chain (NfL), a sensitive fluid biomarker of neurodegeneration (Meeter et al , 2016; Rohrer et al , 2016; Preische et al , 2019), was also not reduced but unexpectedly increased in the cerebrospinal fluid (CSF).”
Schlepckow, K., Kleinberger, G., Fukumori, A., Feederle, R., Lichtenthaler, S. F., Steiner, H., & Haass, C. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707672 · Cited by 261
Self-citationProgranulin, lysosomal regulation and neurodegenerative disease
Kao, A. W., McKay, A., Singh, P. P., Brunet, A., & Huang, E. J. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.36 · Cited by 258
Kleinberger, G., Brendel, M., Mracsko, E., Wefers, B., Groeneweg, L., Xiang, X., Focke, C., Deußing, M., Suárez‐Calvet, M., Mazaheri, F., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201796516 · Cited by 251
Self-citationRoot, J., Merino, P., Nuckols, A., Johnson, M., & Kukar, T. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105360 · Cited by 238
Logan, T., Simon, M. J., Rana, A., Cherf, G. M., Srivastava, A., Davis, S. S., Low, R. L. Y., Chiu, C.-L., Fang, M., Huang, F., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.002 · Cited by 233 · cited 5×
“…et al , 2017; Marschallinger et al , 2020) and a recent study described an age-independent deficit in levels of the lysosomal lipid bis(monoacylglycerol)phosphate (BMP) that was accompanied by an age-dependent accumulation of the GCase substrate glucosylsph-ingosine (GlcSph) (Logan et al , 2021).”
InfluentialSelf-citationThe lysosomal function of progranulin, a guardian against neurodegeneration
Paushter, D. H., Du, H., Feng, T., & Hu, F. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1861-8 · Cited by 230 · cited 1×
“…(Hu et al , 2010; Zhou et al , 2015), where it appears to control activity of hydrolases, such as cathepsins and glucocerebrosidase (GCase) (Gotzl et al , 2016, 2018; Beel et al , 2017; Ward et al , 2017; Paushter et al , 2018; Arrant et al , 2019; Butler et al , 2019b; Logan et al , 2021).”
Games Played by Rogue Proteins in Prion Disorders and Alzheimer's Disease
Aguzzi, A., & Haass, C. (2003) · Science · doi:10.1126/science.1087348 · Cited by 225
Self-citationAutomated Morphological Analysis of Microglia After Stroke
Heindl, S., Gesierich, B., Benakis, C., Llovera, G., Duering, M., & Liesz, A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00106 · Cited by 224
Self-citationEmerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer’s Disease
Lewcock, J. W., Schlepckow, K., Di Paolo, G., Tahirovic, S., Monroe, K. M., & Haass, C. (2020) · Neuron · doi:10.1016/j.neuron.2020.09.029 · Cited by 221 · cited 8×
“Protective microglial functions are promoted by enhancing TREM2 signaling with agonist TREM2 antibodies (Lewcock et al , 2020).”
InfluentialSelf-citationYuan, P., Condello, C., Keene, C. D., Wang, Y., Bird, T. D., Paul, S. M., Luo, W., Colonna, M., Baddeley, D., & Grutzendler, J. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.016 · Cited by 219
Emerging roles of GluN3-containing NMDA receptors in the CNS
Pérez-Otaño, I., Larsen, R. S., & Wesseling, J. F. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.92 · Cited by 214
Meilandt, W. J., Ngu, H., Gogineni, A., Lalehzadeh, G., Lee, S.-H., Srinivasan, K., Imperio, J., Wu, T., Weber, M., Kruse, A. J., et al. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.1871-19.2019 · Cited by 210
Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin
Zhou, X., Sun, L., Bastos de Oliveira, F., Qi, X., Brown, W. J., Smolka, M. B., Sun, Y., & Hu, F. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201502029 · Cited by 203
Thornton, P., Sevalle, J., Deery, M. J., Fraser, G., Zhou, Y., Ståhl, S., Franssen, E. H., Dodd, R. B., Qamar, S., Gomez Perez‐Nievas, B., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707673 · Cited by 200 · cited 1×
“…exists that shedding of TREM2 terminates cell autonomous signaling in myeloid cells (Kleinberger et al , 2014; Schlepckow et al , 2017, 2020; Thornton et al , 2017), these findings suggest that macrophages from GRN-FTLD patients exhibit increased TREM2 signaling, which occurs in conjunction…”
Götzl, J. K., Mori, K., Damme, M., Fellerer, K., Tahirovic, S., Kleinberger, G., Janssens, J., van der Zee, J., Lang, C. M., Kremmer, E., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1262-6 · Cited by 197
Self-citationIndividuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis
Ward, M. E., Chen, R., Huang, H.-Y., Ludwig, C., Telpoukhovskaia, M., Taubes, A., Boudin, H., Minami, S. S., Reichert, M., Albrecht, P., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah5642 · Cited by 193 · cited 2×
“…(Hu et al , 2010; Zhou et al , 2015), where it appears to control activity of hydrolases, such as cathepsins and glucocerebrosidase (GCase) (Gotzl et al , 2016, 2018; Beel et al , 2017; Ward et al , 2017; Paushter et al , 2018; Arrant et al , 2019; Butler et al , 2019b; Logan et al , 2021).”
Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency
Zhang, J., Velmeshev, D., Hashimoto, K., Huang, Y.-H., Hofmann, J. W., Shi, X., Chen, J., Leidal, A. M., Dishart, J. G., Cahill, M. K., et al. (2020) · Nature · doi:10.1038/s41586-020-2709-7 · Cited by 191
Alteration of behavioural phenotype in mice by targeted disruption of the progranulin gene
Kayasuga, Y., Chiba, S., Suzuki, M., Kikusui, T., Matsuwaki, T., Yamanouchi, K., Kotaki, H., Horai, R., Iwakura, Y., & Nishihara, M. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.07.020 · Cited by 189
Progranulin regulates lysosomal function and biogenesis through acidification of lysosomes
Tanaka, Y., Suzuki, G., Matsuwaki, T., Hosokawa, M., Serrano, G., Beach, T. G., Yamanouchi, K., Hasegawa, M., & Nishihara, M. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx011 · Cited by 180
Klein, Z. A., Takahashi, H., Ma, M., Stagi, M., Zhou, M., Lam, T. T., & Strittmatter, S. M. (2017) · Neuron · doi:10.1016/j.neuron.2017.06.026 · Cited by 165
Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo
Beel, S., Moisse, M., Damme, M., De Muynck, L., Robberecht, W., Van Den Bosch, L., Saftig, P., & Van Damme, P. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx162 · Cited by 146
Price, B. R., Sudduth, T. L., Weekman, E. M., Johnson, S., Hawthorne, D., Woolums, A., & Wilcock, D. M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01915-0 · Cited by 146
Brendel, M., Probst, F., Jaworska, A., Overhoff, F., Korzhova, V., Albert, N. L., Beck, R., Lindner, S., Gildehaus, F.-J., Baumann, K., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.167858 · Cited by 145
Self-citationValdez, C., Wong, Y. C., Schwake, M., Bu, G., Wszolek, Z. K., & Krainc, D. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx364 · Cited by 143
Lipidomic and Transcriptomic Basis of Lysosomal Dysfunction in Progranulin Deficiency
Evers, B. M., Rodriguez-Navas, C., Tesla, R. J., Prange-Kiel, J., Wasser, C. R., Yoo, K. S., McDonald, J., Cenik, B., Ravenscroft, T. A., Plattner, F., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.056 · Cited by 137
Ellwanger, D. C., Wang, S., Brioschi, S., Shao, Z., Green, L., Case, R., Yoo, D., Weishuhn, D., Rathanaswami, P., Bradley, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017742118 · Cited by 134
Krabbe, G., Minami, S. S., Etchegaray, J. I., Taneja, P., Djukic, B., Davalos, D., Le, D., Lo, I., Zhan, L., Reichert, M. C., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700477114 · Cited by 132
Precise and efficient scarless genome editing in stem cells using CORRECT
Kwart, D., Paquet, D., Teo, S., & Tessier‐Lavigne, M. (2017) · Nature Protocols · doi:10.1038/nprot.2016.171 · Cited by 129
Self-citationCheng, Q., Danao, J., Talreja, S., Wen, P., Yin, J., Sun, N., Li, C.-M., Chui, D., Tran, D., Koirala, S., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001848 · Cited by 129
Almeida, M. R., Macário, M. C., Ramos, L., Baldeiras, I., Ribeiro, M. H., & Santana, I. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.019 · Cited by 125
Detection of Deleterious On-Target Effects after HDR-Mediated CRISPR Editing
Weisheit, I., Kroeger, J. A., Malik, R., Klimmt, J., Crusius, D., Dannert, A., Dichgans, M., & Paquet, D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107689 · Cited by 125 · cited 2×
“Design and preparation of editing reagents and quality control of edited iPSCs was performed as described previously (Weisheit et al , 2020, 2021).”
Self-citationGötzl, J. K., Brendel, M., Werner, G., Parhizkar, S., Sebastian Monasor, L., Kleinberger, G., Colombo, A., Deussing, M., Wagner, M., Winkelmann, J., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809711 · Cited by 118
Self-citationLiu, B., Le, K. X., Park, M.-A., Wang, S., Belanger, A. P., Dubey, S., Frost, J. L., Holton, P., Reiser, V., Jones, P. A., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.0996-15.2015 · Cited by 114
Fassler, M., Rappaport, M. S., Cuño, C. B., & George, J. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01980-5 · Cited by 110
Huang, M., Modeste, E., Dammer, E., Merino, P., Taylor, G., Duong, D. M., Deng, Q., Holler, C. J., Gearing, M., Dickson, D., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01037-x · Cited by 103
Götzl, J. K., Colombo, A.-V., Fellerer, K., Reifschneider, A., Werner, G., Tahirovic, S., Haass, C., & Capell, A. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0281-5 · Cited by 94
Self-citationAssociation Between Progranulin and Gaucher Disease
Jian, J., Zhao, S., Tian, Q.-Y., Liu, H., Zhao, Y., Chen, W.-C., Grunig, G., Torres, P. A., Wang, B. C., Zeng, B., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.08.004 · Cited by 93
Wu, Y., Shao, W., Todd, T. W., Tong, J., Yue, M., Koga, S., Castanedes-Casey, M., Librero, A. L., Lee, C. W., Mackenzie, I. R., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109581 · Cited by 91
Regulation of cathepsin D activity by the FTLD protein progranulin
Zhou, X., Paushter, D. H., Feng, T., Pardon, C. M., Mendoza, C. S., & Hu, F. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1719-5 · Cited by 89
Diet-dependent regulation of TGFβ impairs reparative innate immune responses after demyelination
Bosch-Queralt, M., Cantuti-Castelvetri, L., Damkou, A., Schifferer, M., Schlepckow, K., Alexopoulos, I., Lütjohann, D., Klose, C., Vaculčiaková, L., Masuda, T., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00341-7 · Cited by 88 · cited 1×
“…and remyelination in models of demyelinating disorders such as multiple sclerosis (Cheng et al , 2018; Cignarella et al , 2020; Lewcock et al , 2020; Price et al , 2020; Schlepckow et al , 2020; Wang et al , 2020; Bosch-Queralt et al , 2021; Ellwanger et al , 2021; Fassler et al , 2021).”
Self-citationFu, J., Guo, O., Zhen, Z., & Zhen, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.603373 · Cited by 83
Progranulin deficiency leads to reduced glucocerebrosidase activity
Zhou, X., Paushter, D. H., Pagan, M. D., Kim, D., Nunez Santos, M., Lieberman, R. L., Overkleeft, H. S., Sun, Y., Smolka, M. B., & Hu, F. (2019) · PLOS ONE · doi:10.1371/journal.pone.0212382 · Cited by 82
Impaired protein degradation in FTLD and related disorders
Götzl, J. K., Lang, C. M., Haass, C., & Capell, A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.008 · Cited by 81
Self-citationAn Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice
Lim, N. K.-H., Moestrup, V., Zhang, X., Wang, W.-A., Møller, A., & Huang, F.-D. (2018) · Journal of Visualized Experiments · doi:10.3791/56774 · Cited by 77
Progranulin Stimulates the In Vitro Maturation of Pro-Cathepsin D at Acidic pH
Butler, V. J., Cortopassi, W. A., Argouarch, A. R., Ivry, S. L., Craik, C. S., Jacobson, M. P., & Kao, A. W. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.01.027 · Cited by 77
Loss of TMEM 106B potentiates lysosomal and FTLD ‐like pathology in progranulin‐deficient mice
Werner, G., Damme, M., Schludi, M., Gnörich, J., Wind, K., Fellerer, K., Wefers, B., Wurst, W., Edbauer, D., Brendel, M., et al. (2020) · EMBO reports · doi:10.15252/embr.202050241 · Cited by 75
Self-citationArrant, A. E., Roth, J. R., Boyle, N. R., Kashyap, S. N., Hoffmann, M. Q., Murchison, C. F., Ramos, E. M., Nana, A. L., Spina, S., Grinberg, L. T., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0872-6 · Cited by 73
Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice
Jadhav, V. S., Lin, P. B. C., Pennington, T., Di Prisco, G. V., Jannu, A. J., Xu, G., Moutinho, M., Zhang, J., Atwood, B. K., Puntambekar, S. S., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00409-0 · Cited by 70
Scarless Genome Editing of Human Pluripotent Stem Cells via Transient Puromycin Selection
Steyer, B., Bu, Q., Cory, E., Jiang, K., Duong, S., Sinha, D., Steltzer, S., Gamm, D., Chang, Q., & Saha, K. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.12.004 · Cited by 69
Woollacott, I. O. C., Bocchetta, M., Sudre, C. H., Ridha, B. H., Strand, C., Courtney, R., Ourselin, S., Cardoso, M. J., Warren, J. D., Rossor, M. N., et al. (2018) · Neurocase · doi:10.1080/13554794.2018.1506039 · Cited by 67
Overhoff, F., Brendel, M., Jaworska, A., Korzhova, V., Delker, A., Probst, F., Focke, C., Gildehaus, F.-J., Carlsen, J., Baumann, K., et al. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00045 · Cited by 66
Self-citationChen, Y., Jian, J., Hettinghouse, A., Zhao, X., Setchell, K. D. R., Sun, Y., & Liu, C.-J. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1703-0 · Cited by 48
Butler, V. J., Cortopassi, W. A., Gururaj, S., Wang, A. L., Pierce, O. M., Jacobson, M. P., & Kao, A. W. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00275 · Cited by 42 · cited 1×
“…(Hu et al , 2010; Zhou et al , 2015), where it appears to control activity of hydrolases, such as cathepsins and glucocerebrosidase (GCase) (Gotzl et al , 2016, 2018; Beel et al , 2017; Ward et al , 2017; Paushter et al , 2018; Arrant et al , 2019; Butler et al , 2019b; Logan et al , 2021).”
Simple and reliable detection of CRISPR-induced on-target effects by qgPCR and SNP genotyping
Weisheit, I., Kroeger, J. A., Malik, R., Wefers, B., Lichtner, P., Wurst, W., Dichgans, M., & Paquet, D. (2021) · Nature Protocols · doi:10.1038/s41596-020-00481-2 · Cited by 39
Self-citationDeußing, M., Blume, T., Kaiser, L., Mahler, C. F., Focke, C., Todica, A. S., Unterrainer, M., Albert, N. L., Lindner, S., von Ungern‐Sternberg, B., et al. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.10.006 · Cited by 38
Self-citation
Cited by
A reference human induced pluripotent stem cell line for large-scale collaborative studies
Pantazis, C. B., Yang, A., Lara, E., McDonough, J. A., Blauwendraat, C., Peng, L., Oguro, H., Kanaujiya, J., Zou, J., Sebesta, D., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.11.004 · Cited by 310
Self-citationvan Lengerich, B., Zhan, L., Xia, D., Chan, D., Joy, D., Park, J. I., Tatarakis, D., Calvert, M., Hummel, S., Lianoglou, S., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-022-01240-0 · Cited by 233
Self-citationDistinct molecular profiles of skull bone marrow in health and neurological disorders
Kolabas, Z. I., Kuemmerle, L. B., Perneczky, R., Förstera, B., Ulukaya, S., Ali, M., Kapoor, S., Bartos, L. M., Büttner, M., Caliskan, O. S., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.009 · Cited by 183
Self-citationQuick, J. D., Silva, C., Wong, J. H., Lim, K. L., Reynolds, R., Barron, A. M., Zeng, J., & Lo, C. H. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02866-y · Cited by 203
“In progranulin-deficient microglia, there is defective clearance and accumulation of myelin debris [72, 73].”
BackgroundTREM2 dependent and independent functions of microglia in Alzheimer’s disease
Hou, J., Chen, Y., Grajales-Reyes, G., & Colonna, M. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00588-y · Cited by 191
Metadata
- Authors
- Reifschneider, A., Robinson, S., van Lengerich, B., Gnörich, J., Logan, T., Heindl, S., Vogt, M. A., Weidinger, E., Riedl, L., Wind, K., Zatcepin, A., Pesämaa, I., Haberl, S., Nuscher, B., Kleinberger, G., Klimmt, J., Götzl, J. K., Liesz, A., Bürger, K., Brendel, M., Levin, J., Diehl‐Schmid, J., Suh, J., Di Paolo, G., Lewcock, J. W., Monroe, K. M., Paquet, D., Capell, A., & Haass, C.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- German Center for Neurodegenerative Diseases (DE)
- Denali Therapeutics (United States) (US)
- Institut für Schlaganfall- und Demenzforschung (DE)
- Technical University of Munich (DE)
- Munich Cluster for Systems Neurology (DE)
- Corresponding author
- Monroe, Kathryn M
- Paquet, Dominik
- Capell, Anja
- Haass, Christian
- ORCID
- Reifschneider, Anika
- Robinson, Sophie
- Gnörich, Johannes
- Logan, Todd
- Heindl, Steffanie
- Vogt, Miriam A
- Weidinger, Endy
- Riedl, Lina
- Zatcepin, Artem
- Pesämaa, Ida
- Nuscher, Brigitte
- Kleinberger, Gernot
- Klimmt, Julien
- Liesz, Arthur
- Bürger, Katharina
- Brendel, Matthias
- Levin, Johannes
- Diehl‐Schmid, Janine
- Suh, Jung
- Di Paolo, Gilbert
- Lewcock, Joseph W
- Monroe, Kathryn M
- Paquet, Dominik
- Capell, Anja
- Haass, Christian
- Venue
- The EMBO Journal
- Published
- 2022-01-12
- Volume
- 41
- Issue
- 4
- Pages
- e109108-e109108
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC8844989
- OpenAlex
- W4206319351
- Cited by
- 89
- References
- 100
- Citations by year
- 2026: 17 · 2025: 18 · 2024: 21 · 2023: 20 · 2022: 13
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- The EMBO Journal (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Open access LMU (Ludwid Maxmilian's Universitat Munchen) (submittedVersion, cc-by-nc-nd)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- DZNE Pub (submittedVersion, cc-by-nc-nd)
- Funders
- Deutsche Forschungsgemeinschaft (EXC 2145 SyNergy‐ID 390857198, BR4580/1‐1, HA1737/16‐1)
- Helmholtz‐Gemeinschaft (ZT‐0027)
- Alzheimers Association (ADSF‐21‐831213‐C)
- Stiftung zur Erforschung der Vaskulären Demenz
- BrightFocus Foundation (ADR AD2019604S)
- Alzheimer Forschung Initiative (19063p)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- TREM2, progranulin deficiency, frontotemporal lobar degeneration, lysosomal dysfunction, neuroprotection, neurofilament light chain, synaptic loss, TDP-43, induced pluripotent stem cell-derived microglia, neurotoxicity
- MeSH terms
- Syk Kinase, Progranulins, Animals, Antibodies, Brain, Disease Models, Animal, Female, Humans, Lysosomes, Male, Membrane Glycoproteins, Mice, Inbred C57BL, Monocytes, Receptors, Immunologic, Microglia, Mice, Knockout, Mice, Frontotemporal Lobar Degeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.